BACKGROUND: Elevated blood pressure (BP), a heritable risk factor for many age-related disorders, is commonly investigated in population and genetic studies, but antihypertensive use can confound study results. Routine methods to adjust for antihypertensives may not sufficiently account for newer treatment protocols (i.e., combination or multiple drug therapy) found in contemporary cohorts. METHODS: We refined an existing method to impute unmedicated BP in individuals on antihypertensives by incorporating new treatment trends. We assessed BP and antihypertensive use in male twins (n = 1,237) from the Vietnam Era Twin Study of Aging: 36% reported antihypertensive use; 52% of those treated were on multiple drugs. RESULTS: Estimated heritability was 0.43 (95% confidence interval (CI) = 0.20-0.50) and 0.44 (95% CI = 0.22-0.61) for measured systolic BP (SBP) and diastolic BP (DBP), respectively. We imputed BP for antihypertensives by 3 approaches: (i) addition of a fixed value of 10/5mm Hg to measured SBP/DBP; (ii) incremented addition of mm Hg to BP based on number of medications; and (iii) a refined approach adding mm Hg based on antihypertensive drug class and ethnicity. The imputations did not significantly affect estimated heritability of BP. However, use of our most refined imputation method and other methods resulted in significantly increased phenotypic correlations between BP and body mass index, a trait known to be correlated with BP. CONCLUSIONS: This study highlights the potential usefulness of applying a representative adjustment for medication use, such as by considering drug class, ethnicity, and the combination of drugs when assessing the relationship between BP and risk factors.
BACKGROUND: Elevated blood pressure (BP), a heritable risk factor for many age-related disorders, is commonly investigated in population and genetic studies, but antihypertensive use can confound study results. Routine methods to adjust for antihypertensives may not sufficiently account for newer treatment protocols (i.e., combination or multiple drug therapy) found in contemporary cohorts. METHODS: We refined an existing method to impute unmedicated BP in individuals on antihypertensives by incorporating new treatment trends. We assessed BP and antihypertensive use in male twins (n = 1,237) from the Vietnam Era Twin Study of Aging: 36% reported antihypertensive use; 52% of those treated were on multiple drugs. RESULTS: Estimated heritability was 0.43 (95% confidence interval (CI) = 0.20-0.50) and 0.44 (95% CI = 0.22-0.61) for measured systolic BP (SBP) and diastolic BP (DBP), respectively. We imputed BP for antihypertensives by 3 approaches: (i) addition of a fixed value of 10/5mm Hg to measured SBP/DBP; (ii) incremented addition of mm Hg to BP based on number of medications; and (iii) a refined approach adding mm Hg based on antihypertensive drug class and ethnicity. The imputations did not significantly affect estimated heritability of BP. However, use of our most refined imputation method and other methods resulted in significantly increased phenotypic correlations between BP and body mass index, a trait known to be correlated with BP. CONCLUSIONS: This study highlights the potential usefulness of applying a representative adjustment for medication use, such as by considering drug class, ethnicity, and the combination of drugs when assessing the relationship between BP and risk factors.
Keywords:
VETSA.; antihypertensive; blood pressure; body mass index; heritability; hypertension; twins
Authors: Carol E Franz; Michael D Grant; Kristen C Jacobson; William S Kremen; Seth A Eisen; Hong Xian; James Romeis; Heather Thompson-Brenner; Michael J Lyons Journal: Twin Res Hum Genet Date: 2007-08 Impact factor: 1.587
Authors: Hendrik R Taal; Germaine C Verwoert; Ayse Demirkan; A Cecile J W Janssens; Kenneth Rice; Georg Ehret; Albert V Smith; Ben F J Verhaaren; Jacqueline C M Witteman; Albert Hofman; Meike W Vernooij; Andre G Uitterlinden; Fernando Rivadeneira; M Arfan Ikram; Daniel Levy; Albert J van der Heijden; Vincent W V Jaddoe; Cornelia M van Duijn Journal: Hypertension Date: 2011-12-27 Impact factor: 10.190
Authors: Doreen M Rabi; Stella S Daskalopoulou; Raj S Padwal; Nadia A Khan; Steven A Grover; Daniel G Hackam; Martin G Myers; Donald W McKay; Robert R Quinn; Brenda R Hemmelgarn; Lyne Cloutier; Peter Bolli; Michael D Hill; Thomas Wilson; Brian Penner; Ellen Burgess; Maxime Lamarre-Cliché; Donna McLean; Ernesto L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Arun Chockalingam; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Kevin D Burns; Marcel Ruzicka; Norman R C Campbell; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Tavis S Campbell; M Patrice Lindsay; Robert J Herman; Pierre Larochelle; Ross D Feldman; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Luc Trudeau; Simon L Bacon; Robert J Petrella; Richard Lewanczuk; James A Stone; Denis Drouin; Jean-Martin Boulanger; Mukul Sharma; Pavel Hamet; George Fodor; George K Dresser; S George Carruthers; George Pylypchuk; Richard E Gilbert; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Philip A McFarlane; Robert A Hegele; Luc Poirier; Sheldon W Tobe Journal: Can J Cardiol Date: 2011 Jul-Aug Impact factor: 5.223
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Alexandra Dudina; Marie Therese Cooney; Dirk De Bacquer; Guy De Backer; Pierre Ducimetière; Pekka Jousilahti; Ulrich Keil; Alessandro Menotti; Inger Njølstad; Rafael Oganov; Susana Sans; Troels Thomsen; Aage Tverdal; Hans Wedel; Peter Whincup; Lars Wilhelmsen; Ronan Conroy; Anthony Fitzgerald; Ian Graham Journal: Eur J Cardiovasc Prev Rehabil Date: 2011-06-03
Authors: Alexander V Murray; Wolfgang Koenig; Juan Garcia-Puig; Samir Patel; Alkaz Uddin; Jack Zhang Journal: J Clin Hypertens (Greenwich) Date: 2012-08-28 Impact factor: 3.738
Authors: Stephanie K Tanamas; Robert L Hanson; Robert G Nelson; William C Knowler Journal: J Diabetes Complications Date: 2017-01-20 Impact factor: 2.852
Authors: Matthew S Panizzon; Richard L Hauger; Megan Sailors; Michael J Lyons; Kristen C Jacobson; Ruth Murray McKenzie; Brinda Rana; Terrie Vasilopoulos; Eero Vuoksimaa; Hong Xian; William S Kremen; Carol E Franz Journal: Obesity (Silver Spring) Date: 2015-11-02 Impact factor: 5.002
Authors: Natalia Petruski-Ivleva; Anthony J Viera; Daichi Shimbo; Paul Muntner; Christy L Avery; Andrea L C Schneider; David Couper; Anna Kucharska-Newton Journal: Hypertension Date: 2016-04-04 Impact factor: 10.190
Authors: Christine Fennema-Notestine; Linda K McEvoy; Randy Notestine; Matthew S Panizzon; Wai-Ying Wendy Yau; Carol E Franz; Michael J Lyons; Lisa T Eyler; Michael C Neale; Hong Xian; Ruth E McKenzie; William S Kremen Journal: Neuroimage Clin Date: 2016-10-06 Impact factor: 4.881
Authors: Maximillian T Bourdillon; Rebecca J Song; Ibrahim Musa Yola; Vanessa Xanthakis; Ramachandran S Vasan Journal: J Am Heart Assoc Date: 2022-03-09 Impact factor: 6.106